Eli Lilly CDR (LLY)
(Delisted)NEO
Real-time Data
01:30 PM
Day's Range
44.0652 wk Range
25.42Overview - LLY - Eli Lilly CDR
Key Statistics
Trading
Volume
7.75K
Average Volume
6.67K
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LLY - Eli Lilly CDR
Peers - LLY - Eli Lilly CDR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NEO.
- LLYNEOEli Lilly CDR1.55TMarket Cap+43.38%52-week change58.49P/E (Trailing)‪30.98%‬Profit Margin
- ABBVNEOAbbVie Inc. CDR641.92BMarket Cap+19.68%52-week change194.37P/E (Trailing)‪4.00%‬Profit Margin
- NVSNEONovartis AG426.16BMarket Cap+20.35%52-week change18.81P/E (Trailing)‪75.82%‬Profit Margin
- AMGNNEOAmgen Inc. Canadian Depositary Receipt316.10BMarket Cap+31.06%52-week change38.21P/E (Trailing)‪17.38%‬Profit Margin
- GILDNEOGilead Sciences Inc. CDR249.24BMarket Cap+20.33%52-week change22.23P/E (Trailing)‪27.88%‬Profit Margin
- ROCHNEORoche Holding Ltd.220.56BMarket Cap+30.06%52-week change10.63P/E (Trailing)‪19.60%‬Profit Margin
Profile Summary - LLY - Eli Lilly CDR
About
Eli Lilly CDR is a Canadian Depositary Receipt (CAD Hedged) providing Canadian investors exposure to Eli Lilly and Company, a leading global pharmaceutical firm founded in 1876 and headquartered in Indianapolis, Indiana. Eli Lilly engages in the discovery, development, manufacture, and sale of innovative prescription…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
